1. Stocks
  2. Suven Pharmaceuticals Ltd.
  3. Swot
swot-logo

Suven Pharmaceuticals Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Suven Pharmaceuticals Ltd. has 15 Strengths, 11 Weaknesses, 7 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Stock passes majority of CANSLIM Investment criteria

Consistent Highest Return Stocks over Five Years - Nifty500

Expensive Performers (DVM)

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Company with Low Debt

Increasing profits every quarter for the past 4 quarters

Increasing Revenue every quarter for the past 2 quarters

Book Value per share Improving for last 2 years

Company with Zero Promoter Pledge

High Volume, High Gain

Top Gainers

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Degrowth in Revenue and Profit

Declining Net Cash Flow : Companies not able to generate net cash

Annual net profit declining for last 2 years

Declining profitability: Falling ROCE

Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Companies with Upcoming Results

Broker price or reco upgrades in last month

Brokers upgraded recommendation or target price in the past three months

Big Deal (Insider and SAST) buys last month greater than 1% of total shares

Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month

FII / FPI or Institutions increasing their shareholding

Broker price or reco upgrades in last month

MFs decreased their shareholding last quarter

Rising Delivery Percentage Compared to Prev Day

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Quarterly Net Profit with falling Profit Margin (YoY)